acarix

Corporate Information, English, General meeting, IR, Listing Regulation, News, Regulatory, Report of the AGM

November 18, 2024

11 May 2022

Announcement from Acarix’s annual general meeting

Press release Malmö, Sweden, May 11, 2022   Announcement from Acarix's annual general meeting The annual general ...

Continue reading

acarix

Corporate Information, IR, News, Other Corporate Information, Swedish

November 18, 2024

06 May 2022

Acarix presenterar på Naventus Health Care Summit 2022

Pressmeddelande Malmö, 6 maj 2022   Acarix presenterar på Naventus Health Care Summit 2022 Helen Ljungdahl ...

Continue reading

acarix

Corporate Information, English, IR, News, Other Corporate Information

November 18, 2024

06 May 2022

Acarix presents at Naventus Health Care Summit 2022

Press release Malmö, Sweden, May 6, 2022   Acarix presents at Naventus Health Care Summit 2022 Helen Ljungdahl Ro...

Continue reading

acarix

Corporate Information, General meeting, IR, Listing Regulation, News, Notice, Regulatory, Swedish

November 18, 2024

11 Apr 2022

Kallelse till årsstämma i Acarix AB

Kallelse till årsstämma i Acarix AB Aktieägarna i Acarix AB, org.nr 559009-0667, ("Bolaget") kallas härmed till &...

Continue reading

acarix

Corporate Information, English, General meeting, IR, Listing Regulation, News, Notice, Regulatory

November 18, 2024

11 Apr 2022

Notice of Annual General Meeting in Acarix AB

Notice of Annual General Meeting in Acarix AB The shareholders of Acarix AB, reg. no. 559009-0667, (the "Company"), are hereby convene...

Continue reading

acarix

Corporate Information, English, IR, MAR, News, Other Corporate Information, Regulatory

November 18, 2024

01 Apr 2022

FDA requests supplementary information for Acarix breakthrough designation request for heart failure diagnosis

Press release (MAR)Malmö, Sweden, April 1, 2022   FDA requests supplementary information for Acarix br...

Continue reading

acarix

Corporate Information, IR, MAR, News, Other Corporate Information, Regulatory, Swedish

November 18, 2024

01 Apr 2022

FDA begär kompletterande information för Acarix ansökan om Breakthrough Designation-status för diagnos av hjärtsvikt

Pressmeddelande (MAR)Malmö, Sverige, 1 april 2022   FDA begär kompletterande information för Acar...

Continue reading

acarix

Corporate Information, English, IR, MAR, News, Order, Regulatory, Sales

November 18, 2024

11 Mar 2022

Acarix receives strategic order for the CADScor®System in US

Press release (MAR)Malmö, Sweden, March 11, 2022   Acarix receives strategic order for the CADScor®System in U...

Continue reading

acarix

Corporate Information, IR, MAR, News, Order, Regulatory, Sales, Swedish

November 18, 2024

11 Mar 2022

Acarix erhåller strategisk order av CADScor®System i USA

Pressmeddelande (MAR)Malmö, 11 mars 2022   Acarix erhåller strategisk order av CADScor®System i USA Aca...

Continue reading

acarix

Corporate Information, English, IR, News, Other Corporate Information

November 18, 2024

10 Mar 2022

Acarix presents at the Redeye Artificial Intelligence Seminar 2022

Press release Malmö, Sweden, March 10, 2022   Acarix presents at the Redeye Artificial Intelligence Seminar 2022 ...

Continue reading

acarix

Corporate Information, IR, News, Other Corporate Information, Swedish

November 18, 2024

10 Mar 2022

Acarix presenterar vid Redeye seminarium om artificiell intelligens 2022

Pressmeddelande Malmö, 10 mars 2022   Acarix presenterar vid Redeye seminarium om artificiell intelligens 2022. D...

Continue reading

acarix

Corporate Information, IR, News, Other Corporate Information, Swedish

November 18, 2024

18 Feb 2022

Acarix kapitalmarknadsdag: Uppdatering kring strategi, marknader och målsättningar

Pressmeddelande Malmö, 18 februari 2022   Acarix kapitalmarknadsdag: Uppdatering kring strategi, marknader och m...

Continue reading